Sebastian Fain is a Partner at Gibson Dunn in New York City, where he co-heads the firm's Cross Border M&A practice. Specializing in Corporate, M&A, Capital Markets, and High Yield, Sebastian brings a wealth of experience in mergers and acquisitions, activism defense, and corporate governance. His career includes significant roles at Freshfields and Wachtell Lipton, where he honed his expertise in both domestic and cross-border transactions. Notably, Sebastian has advised on major deals such as AstraZeneca's $39 billion acquisition of Alexion Pharmaceuticals and Universal Music Group's $40 billion spin-off from Vivendi SE. Recognized as a Dealmaker of the Year by The American Lawyer, he is a trusted advisor to boards and C-suites on critical corporate matters.
LinkedIn
